JP2003510285A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510285A5
JP2003510285A5 JP2001526187A JP2001526187A JP2003510285A5 JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5 JP 2001526187 A JP2001526187 A JP 2001526187A JP 2001526187 A JP2001526187 A JP 2001526187A JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5
Authority
JP
Japan
Prior art keywords
echinacea
amount
composition
chinacea
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001526187A
Other languages
English (en)
Japanese (ja)
Other versions
JP4559683B2 (ja
JP2003510285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/000931 external-priority patent/WO2001022977A2/en
Publication of JP2003510285A publication Critical patent/JP2003510285A/ja
Publication of JP2003510285A5 publication Critical patent/JP2003510285A5/ja
Application granted granted Critical
Publication of JP4559683B2 publication Critical patent/JP4559683B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001526187A 1999-09-30 2000-08-11 Ｅｃｈｉｎａｃｅａサプリメントおよびその製造方法 Expired - Fee Related JP4559683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15719499P 1999-09-30 1999-09-30
US60/157,194 1999-09-30
PCT/CA2000/000931 WO2001022977A2 (en) 1999-09-30 2000-08-11 Echinacea supplement and method of manufacture

Publications (3)

Publication Number Publication Date
JP2003510285A JP2003510285A (ja) 2003-03-18
JP2003510285A5 true JP2003510285A5 (enExample) 2005-09-29
JP4559683B2 JP4559683B2 (ja) 2010-10-13

Family

ID=22562708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526187A Expired - Fee Related JP4559683B2 (ja) 1999-09-30 2000-08-11 Ｅｃｈｉｎａｃｅａサプリメントおよびその製造方法

Country Status (14)

Country Link
US (2) US6511683B1 (enExample)
EP (1) EP1220680B1 (enExample)
JP (1) JP4559683B2 (enExample)
CN (1) CN1240403C (enExample)
AT (1) ATE388718T1 (enExample)
AU (1) AU777453B2 (enExample)
CA (1) CA2379581C (enExample)
DE (1) DE60038308T2 (enExample)
DK (1) DK1220680T3 (enExample)
ES (1) ES2303512T3 (enExample)
HK (1) HK1048943B (enExample)
NZ (1) NZ517371A (enExample)
PT (1) PT1220680E (enExample)
WO (1) WO2001022977A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407712A1 (en) * 2000-05-05 2001-11-15 Bioniche Life Sciences Inc. Use of echinacea as a hematinic agent
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
EP1297751A1 (de) * 2001-10-01 2003-04-02 Bogar AG Oral zu verabreichende Zubereitung
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
ITMI20021692A1 (it) * 2002-07-30 2002-10-29 Indena Spa Polisaccaride di echinacea angustifolia.
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
CA2522088A1 (en) * 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
CN1297568C (zh) * 2003-08-08 2007-01-31 吉林威威药业股份有限公司 一种松果菊多糖、其制备方法及其在制备治疗抗病毒、抗菌及抗sars药物上的用途
US20050175721A1 (en) * 2004-02-06 2005-08-11 Brovelli Ernesto A. Method of augmenting the immune-modulatory activity of standardized Echinacea preparations
US8003136B2 (en) * 2004-03-03 2011-08-23 Randy Beavers Standardization of botanical products utilizing biological activity as a marker
AU2005259854C1 (en) * 2004-07-07 2011-06-02 Integria Healthcare (Australia) PTY LTD An Echinacea formulation
GB2432788C (en) * 2004-07-07 2018-06-27 Integria Healthcare Australia Pty Ltd An echinacea formulation
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
US7829098B2 (en) * 2005-11-08 2010-11-09 Vita Green Health Products Co., Ltd Herbal powder extracts and methods of preparing and using the same
CA2632607A1 (en) * 2005-12-09 2007-06-21 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
CN101032541B (zh) * 2006-07-28 2011-05-11 成都地奥九泓制药厂 一种紫锥菊提取物及其制备方法和含量测定方法
CH699653B1 (de) * 2008-09-08 2010-05-14 Bioforce Ag Roggwil Tg Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen.
US8273385B1 (en) 2008-10-17 2012-09-25 Thres Flo, LLC Oral rinse composition and method
EP2766009B1 (en) * 2011-10-11 2019-10-09 ELC Management LLC Method and compositions for treating skin
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
KR102440040B1 (ko) * 2013-03-14 2022-09-02 마리 케이 인코포레이티드 화장품 조성물들
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
DE102017206827A1 (de) 2017-04-24 2018-10-25 Roman Gehre Gewinnung und Nutzung von Polyphenolen, insbesondere Cichoriensäure, aus Pflanzen der Gattung Posidonia
JP7488573B2 (ja) * 2021-01-14 2024-05-22 株式会社山田養蜂場本社 マクロファージ活性剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
DE3744570A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen mit immunstimulierender wirkung und verfahren zu ihrer herstellung
DE3744571A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen zur stimulierung des immunsystems und verfahren zu ihrer herstellung
CH676931A5 (en) * 1988-08-02 1991-03-28 Spagyros S A Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc.
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US5455033A (en) * 1993-05-21 1995-10-03 Degree/Silverman M.D. Inc. Medicinal composition for treatment of inflammation
FR2742987B1 (fr) * 1996-01-03 1998-04-03 Lvmh Rech Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
CA2307614A1 (en) * 1997-10-23 1999-04-29 Elliot P. Friedman Pharmaceutical grade echinacea
US6217878B1 (en) * 1999-08-13 2001-04-17 Amway Corporation Method of preparing echinacea powder

Similar Documents

Publication Publication Date Title
JP2003510285A5 (enExample)
JP2005516946A5 (enExample)
JP2003514758A5 (enExample)
JP2004532810A5 (enExample)
JP2004523498A5 (enExample)
JP2004529078A5 (enExample)
JP2003506345A5 (enExample)
JP2003503454A5 (enExample)
WO2004091532A3 (en) Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
WO2003007985A3 (en) Capsular polysaccharide solubilisation and combination vaccines
JP2003520232A5 (enExample)
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
HUP0203821A2 (hu) Új oligoszacharidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
MXPA00012199A (es) Composicion de goma de gelano modificada, proceso para la preparacion de la misma y uso de esta.
JP2003508328A5 (enExample)
DE69922880D1 (de) Enzymzusammensetzungen, die in vivo Oligosaccharide bilden können
JP2006507484A5 (enExample)
NO20032371L (no) Makrolidsolvater
JP2005501968A5 (enExample)
MXPA05005572A (es) Esteres de acido aldonico, metodos para producir el mismo y metodos para producir ingredientes activos farmaceuticos acoplados a polisacaridos o derivados de polisacaridos en grupos de aminos libres.
JO2249B1 (en) A compound of 6.3-dialkyl-6.5-dihydro-4-hydroxy-biran-2-one
JP2002240244A5 (enExample)
CA2438622A1 (en) Compositions containing creatine and creatinine
ME00568A (en) Ciclesonide-containing aqueous pharmaceutical composition
JPH09235233A5 (enExample)